Skip to main content
Caplight Logo









RenovoDerm

RenovoDerm

Private
Dublin, OhioHealthcare & Life Scienceshttps://renovoderm.tech

Last Round

Pre Seed

Feb 8, 2023

Total Funding Raised

$8.65M

Company Overview

RenovoDerm is a medical device company that develops and manufactures wound care products designed to enhance tissue regeneration.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Advanced Materials, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

wound matrixadvanced wound carenanofiber scaffoldtissue regenerationelectrospun nanofibersregenerative medicinebioabsorbable scaffoldextracellular matrix mimicchronic wound treatmentmedical devicesMedTechsynthetic skin graftbiomaterialsdiabetic ulcer treatmentB2G sales

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

RenovoDerm Comparables

Compare RenovoDerm with similar companies based on industry and business-model similarity.

RenovoDerm comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Engineered Tissue Solutions
84%
SweetBio
84%
Imbed Biosciences
78%

RenovoDerm Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedFeb 8, 2023
Series ANov 16, 2021
VC RoundJan 11, 2021
VC RoundNov 29, 2018
SeedDec 7, 2017

Key People

Founding team and executive leadership

Ronald Bracken

Chief Executive Officer

Executive Team

RenovoDerm Filings

Explore SEC and related filing metadata, where available.

RenovoDerm filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about RenovoDerm's valuation, stock price, and market status.

Is RenovoDerm a public or private company?

RenovoDerm is a private company.

What is the current stock price of RenovoDerm?

RenovoDerm is a private company, so its shares have no public market price. Caplight tracks RenovoDerm's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is RenovoDerm worth (valuation)?

Valuation information for RenovoDerm is not publicly available.

Can I buy RenovoDerm stock?

RenovoDerm shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was RenovoDerm's last funding round?

RenovoDerm's most recent funding round was Pre Seed on February 8, 2023.

Who are the main investors in RenovoDerm?

Investor information for RenovoDerm is not publicly disclosed.

Will RenovoDerm IPO soon?

No public IPO plans have been announced for RenovoDerm.

How can I track RenovoDerm secondary market activity?

Caplight tracks bids, offers, and trades in RenovoDerm's shares on secondary markets.

Firmographic Details

HeadquartersDublin, Ohio
Employee Range5
Year Founded2016
Last FundingFeb 8, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?